Welcome to our insightful webinar hosted by Dr. Elizabeth Leroux, Chair of Migraine Canada, where we delve into the transformative potential of CGRP antibodies for migraine prevention. Join us as we explore the science behind CGRP, its role in migraine management, and the efficacy of treatments like Aimovig, Emgality, and Ajovy. Discover how these therapies work, their potential side effects, and insights on navigating cost and insurance coverage. Whether you’re new to migraine management or seeking advanced treatment options, this session promises essential knowledge and practical advice. Stay informed and empowered in your journey towards better migraine control.
Click Here for Video Transcription
0:00 [Music]
0:31 good afternoon everyone
0:32 uh my name is dr elizabeth leroux i am
0:36 the chair of migraine canada and it’s my
0:38 pleasure to welcome you
0:40 on this sunday webinar on cgrp
0:43 antibodies
0:44 for migraine prevention a few
0:47 housekeeping things
0:49 um this webinar will be recorded it is
0:52 recorded
0:53 it will be uh posted on our on our
0:55 youtube channel
0:56 and website um it depending on the
0:59 quality it might be re-recorded
1:01 so it might be slightly different than
1:03 what you’re seeing
1:05 uh please do support us by sharing
1:08 our website our facebook if you’re on
1:11 social media
1:12 but also raise awareness about migraine
1:14 in your network
1:18 so remember that this is a webinar on
1:20 medical therapy
1:22 we do provide information and i am a
1:24 neurologist specialized in headache
1:27 but we cannot provide medical advice for
1:29 your specific case
1:30 so the information discussed might not
1:32 apply to you
1:34 and always discuss whatever medical
1:36 therapy you want to try
1:37 with your own health care provider who
1:39 knows everything about your story
1:42 also do not miss our next webinars we
1:44 have two planned exciting ones with
1:47 christy tate nurse practitioner who’s
1:49 going to talk to us about the story of
1:51 migraine diagnostic pitfalls and how
1:53 migraine sometimes
1:54 is not well diagnosed and then um
1:58 november 29th dr suvendrini elena
2:01 who will talk about women migraine and
2:03 advocacy
2:05 so today i want to talk to you about
2:08 different things all right so basics
2:11 about migraine prevention some of you
2:13 might be very familiar with this but
2:14 others might not be
2:16 we’ll talk about the story and the
2:17 science of cgrp
2:19 then we’ll talk about those treatments
2:21 hov emma vig and galilee
2:23 do they work and what type of side
2:25 effects do they have
2:27 and then we’ll talk also about the
2:29 sensitive topic of
2:30 cost and access and insurance coverage
2:33 so some of you might actually
2:35 already be taking these treatments and
2:37 that might be the part that interests
2:39 you
2:39 the most the whole thing should last
2:42 approximately 40 minutes and then i’ll
2:44 be very glad to take your questions
2:46 in the chat box um the best i can of
2:49 course uh
2:50 in a safely manner all right so let’s
2:51 get started so basics of migraine
2:54 prevention so this is the first
2:56 uh part well maybe it will be reassuring
3:00 to you
3:01 if you live with migraine that first is
3:04 a common problem
3:05 and many people live with migraine and
3:08 have difficulty with their sleep
3:10 their work their personal activities
3:12 they do miss
3:13 occasions they do miss work and so in
3:16 this survey done
3:17 in canada you can see that a lot of
3:20 people
3:20 a quarter of them had difficulty
3:23 attending activities
3:25 three-quarters of them know what it
3:27 means to have a bad night because of a
3:29 migraine
3:30 a third of them miss work and a lot of
3:33 them had to adapt their work activities
3:35 because of migraine so migraine symptoms
3:38 have a significant
3:39 impact on someone’s life both
3:42 professional
3:43 and personal of course that depends on
3:46 how much migraine you have if you have
3:49 three migraines per year you may have
3:51 very
3:51 little impact but if you have chronic
3:53 migraine and you have
3:55 20 days per month with a headache or a
3:57 migraine attack
3:59 of course your life will be
4:00 significantly impacted
4:02 so this continuum of frequency is
4:05 typical of migraine
4:06 and if you live with migraine you know
4:08 this but many people
4:10 do not understand that and that’s why
4:12 some people
4:13 will see migraine as just a headache
4:15 that’s just a little nuisance you take
4:17 an advil
4:18 but we all know if you have frequent
4:21 attacks how debilitating
4:22 that can be so when we approach migraine
4:27 therapy and this is also a basic
4:29 there’s always three parts so your
4:31 doctor should address those three parts
4:33 with you
4:34 ideally the behavioral aspect is
4:36 extremely important
4:38 it’s adapting lifestyle managing
4:40 triggers
4:41 stabilizing the brain as much as we can
4:44 to avoid attacks
4:45 treating the attack is the world of
4:47 acute therapy which we won’t talk about
4:49 today
4:50 and then preventive therapy is medical
4:53 approaches to stabilize the brain
4:56 you may some of you might have seen our
4:58 previous webinar which
5:00 is on our youtube channel about the
5:02 causes of migraine
5:03 and i did present this ping pong theory
5:06 of migraine
5:07 the ping pong theory said that migraine
5:10 is
5:11 a problem with the software the chemical
5:13 software of the brain
5:15 and there’s two way really to tackle
5:17 frequent attacks
5:18 the first is to kind of manage
5:21 the load the burden the triggers
5:24 whatever
5:24 is triggering the attack by stabilizing
5:27 your lifestyle
5:28 addressing other diseases psychological
5:32 and physical health and trying to treat
5:35 peripheral problems
5:36 so it’s true that if you have sleep
5:38 apnea or bruxism or depression
5:41 it might lead to more migraine and by
5:44 addressing that
5:45 you might get better but then on the
5:47 other side
5:48 i have lots of patients who do yoga
5:51 they eat perfectly well they they are
5:54 masters of time management
5:56 and still they have frequent attack and
5:59 that’s where
6:00 medical prevention is indicated to kind
6:02 of manipulate the software
6:05 with medications to make your brain more
6:08 resistant
6:08 to migraine attack so you have less of
6:11 them
6:12 which is the ultimate goal so our goal
6:15 when we discuss
6:16 prevention is to decrease the frequency
6:19 and intensity of attacks to improve your
6:22 quality of life
6:23 this is the goal of migraine therapy so
6:26 for example if you live with chronic
6:28 migraine
6:29 means maybe you start with you know 10
6:31 severe days
6:32 12 mile days that’s 22 days with a
6:35 headache or a migraine attack
6:37 you may miss work and attacks might be
6:39 difficult to treat
6:40 so that’s a very disabled baseline
6:43 and then if you have a 50 response i
6:46 will
6:46 go back to this 50 response concept
6:50 well then it means you may go down to
6:52 five severe days
6:53 five mile days maybe you don’t miss work
6:56 anymore
6:56 and you have a tax that you can finally
6:59 control with triptans or
7:01 anti-inflammatories so that’s our goal
7:04 unfortunately so far we do not have
7:08 universal cures one-size-fits-all things
7:10 for migraine
7:11 usually we deal with it we decrease the
7:14 numbers that’s our goal
7:16 i want to do my little pitch on the
7:17 canadian migraine tracker
7:19 a useful tool a free app you can use
7:22 to actually record your attacks with a
7:25 simple
7:26 mild moderate severe one two three
7:28 approach
7:29 this app is actually very handy now
7:32 during covid time
7:33 because you can send your diary to your
7:36 physician
7:37 my patients are doing that they’re
7:39 sending their diary by email
7:41 to me before my their appointment so i
7:44 can review it as i speak on the phone
7:46 with them or
7:47 on telemedicine so if you haven’t tried
7:50 it
7:50 you might consider it also remember and
7:53 we’ll talk about coverage later
7:55 that now we are a bit more inclined to
7:58 be precise about
8:00 migraine evaluation because insurance
8:02 companies
8:03 might ask for precise headache counts to
8:06 see if whatever they’re paying for
8:08 they’re covering for you
8:10 including the antibodies and botox
8:12 therapy
8:13 just to see are you improving so having
8:16 a headache diary
8:17 is medically indicated it’s really
8:20 practical
8:20 but now it may actually become something
8:23 that may lead to coverage issues
8:26 all right so before the cgrp antibodies
8:30 arrived what did we have for treating
8:33 migraine
8:34 and some of you if you’re experienced
8:36 with migraine you probably know those
8:38 names
8:38 right so we have medications medications
8:41 that were not designed to treat migraine
8:44 they were anti-depressants n-type blood
8:47 pressure or anti-hypertension
8:49 anti-seizure or anti-epileptics
8:52 how do they work we don’t necessarily
8:55 know exactly but they do
8:57 all of them manipulate the software of
8:59 your brain
9:00 to make it more resistant to migraine
9:02 and all of them have been tried
9:04 in studies and clinical studies so you
9:07 might
9:08 know the the most commonly prescribed
9:10 are tricyclics like
9:11 amitriptyline or elevil nor triptyline
9:14 or aventil
9:15 just to make our lives easier there are
9:17 always two names to those things right
9:20 so we have also blood pressure pills
9:22 proprano wall or enderol
9:24 natholol or corguard topiramate
9:27 is a very famous one as well and then
9:30 in the second line uh we have other
9:33 options
9:34 then the vaccine verapamil you see the
9:36 names
9:37 right so what your doctor is gonna do
9:40 usually
9:40 is to say okay you need prevention um
9:44 which is which could work for you do you
9:46 have high blood pressure
9:48 very good i’m gonna give you that drug
9:49 that treats blood pressure
9:51 do you have epilepsy i’m gonna give you
9:53 that drug and then you
9:54 start the quest of oral prevention
9:58 why i’m saying that it’s because there’s
10:00 no way for us to know which one’s gonna
10:03 work
10:03 and it’s really jumping after uh
10:07 jumping through multiple hoops to find
10:09 the one that works
10:11 do they work they actually do right
10:14 so it might be if you’re listening this
10:17 webinar it’s because they didn’t work
10:19 for you but they work for 50
10:22 of people so that’s the ballpark we
10:24 learn when we do
10:25 neurology 50 of people
10:28 get a 50 response that’s the ballpark we
10:32 get
10:33 so here i put a half a half kind of in
10:35 10 people who try
10:37 five will have some degree of response
10:39 and five
10:40 will not so that’s better than nothing
10:44 but what do we know we know that if you
10:46 start
10:47 oral prevention after one year and you
10:50 have
10:50 chronic migraine this is data on chronic
10:53 migraine
10:54 well eight over ten people will have
10:57 stopped their drug
10:58 by the end of the year what does that
11:00 mean it’s not great
11:02 it means somehow that people find
11:05 that they do not have benefit enough
11:09 to keep the drug on and maybe they have
11:12 a little benefit
11:13 but they have side effects and they stop
11:15 the drug because of side effects
11:17 so that’s one of the big problem so that
11:20 means that
11:20 instead of having you know let’s say
11:22 five happy campers
11:24 over 10 trying an oral mid we have
11:27 two happy campers who decide to keep the
11:29 drug because five of them did not get
11:32 better
11:32 and maybe two or three of them actually
11:35 had
11:35 disabling side effects so that’s a
11:38 problem
11:39 so we were really hoping in migraine
11:42 world for something better
11:44 to come along and also something that
11:47 was based
11:48 on science and not just serendipity
11:51 okay let’s take a pause little breath
11:55 before we move to the next portion
11:58 the cgrp story so what is cgrp
12:02 it’s calcitonin gene related peptide
12:05 we’ll just call it cgrp this is
12:08 something we all have in our bodies okay
12:10 this is not a toxic product this is
12:12 something that plays
12:13 many roles in our vascular system in our
12:16 skin system
12:17 and of course in our brains right so
12:20 this is something a peptide a protein
12:23 that is normally present in the body and
12:25 it’s not a bad thing it does
12:27 do things for us right but it does play
12:30 a role in migraine
12:32 remember and if you want to see the
12:34 other youtube video
12:36 little pitch here about the cause of
12:38 migraine uh you can go on youtube and
12:40 look at this one
12:41 but just as a reminder the idea is the
12:44 migraine pain
12:45 comes not from the eye or the neck or
12:48 the temples or the jaw
12:50 we think it comes from the meninges and
12:52 the arteries
12:53 inside the brain and those meninges and
12:56 arteries are just
12:57 filled with sensory nerves that can
12:59 cause pain
13:00 and that’s what we think that is the
13:02 cause of the migraine pain the key cause
13:05 why is there pain during a migraine
13:07 attack it’s because the brain
13:10 exposed the triggers decides to sprinkle
13:13 little inflammatory things like natural
13:16 cayenne pepper
13:17 right on your sensitive meninges and
13:19 arteries
13:20 and that leads to inflammation and you
13:23 know inflammation when you have a
13:25 sunburn
13:25 or you cut yourself or you you bruise
13:27 yourself the skin
13:29 becomes very hypersensitive it may
13:31 become swollen and
13:32 red and then something that you know
13:35 doesn’t hurt
13:36 starts to hurt sounds familiar because
13:38 that’s exactly what happens during
13:40 a migraine where your skin might
13:42 actually become
13:43 sensitive and your whole brain is
13:46 actually sensitive to light and sound
13:49 what type of science do we have to prove
13:52 that cgrp is involved
13:54 in migraine let’s say a lot over 20
13:57 years
13:58 we built up i mean not me great
14:01 researchers
14:02 they built up proofs that cgrp
14:05 if you give it to a person with migraine
14:08 it will trigger an attack
14:10 there’s more cgrp in the blood during a
14:12 migraine attack
14:13 and if you block cgrp you block migraine
14:16 so we have a strong we call it
14:19 scientific rational to block cgrp
14:23 how do we block cgrp okay
14:26 so usually we take medications that we
14:29 take they go into our blood they go in
14:30 our system
14:31 and they go and bind different receptors
14:34 and
14:34 and then they exert their action on our
14:37 bodies
14:38 antibodies are just a kind of molecule
14:42 and we have them naturally in our bodies
14:44 um they usually target
14:46 uh infections like viruses viruses
14:49 or bacteria or whatever tumors
14:53 and they activate an immune response so
14:55 they have
14:56 targets and when they see the target
14:58 they stop the target
15:00 so now we have the capacity to create
15:02 antibodies
15:03 to target certain things like cjrp
15:07 or its receptor so that’s how an
15:09 antibody work
15:11 the entire body is nice because it does
15:13 not go through the liver
15:14 or the kidney and it does not interact
15:17 with other medications
15:19 which is very nice
15:28 [Music]